Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pseudomonic Acid (CAS 12650-69-0)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
Mupirocin; Bactroban; Mupirocine; Mupirocinum; Centany; Mupirocina; Plasimine; Bactroban Nasal
Application:
Pseudomonic Acid is an antibiotic inhibitor of isoleucyl-tRNA synthetase
CAS Number:
12650-69-0
Purity:
>95%
Molecular Weight:
500.62
Molecular Formula:
C26H44O9
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Pseudomonic Acid, also known as mupirocin, is an antibiotic that can be found in Pseudomonas fluorescens which strongly inhibits protein and RNA synthesis. Inhibition of protein synthesis was reversed by isoleucine and Pseudomonic Acid was shown to inhibit IleRS (isoleucyl-tRNA synthetase) in vitro. This enzyme is for the synthesis of bacterial proteins by attaching the amino acid isoleucine to its corresponding tRNA. By inhibiting this enzyme, Pseudomonic Acid effectively stops the production of proteins necessary for bacterial growth and replication, leading to the bacteria′s death. Pseudomonic Acid also demonstrates weak inhibitory action on FARSL (phenylalanyl-tRNA synthetase). Efficacy against staphylococci and streptococci including multiply resistant Staphylcoccus aureus and Staphylococcus epidermidis is reported with Pseudomonic Acid.


Pseudomonic Acid (CAS 12650-69-0) References

  1. Structural changes induced by mupirocin in Staphylococcus aureus cells.  |  Thomas, DG., et al. 1999. Int J Antimicrob Agents. 13: 9-14. PMID: 10563399
  2. Resistance to and synthesis of the antibiotic mupirocin.  |  Thomas, CM., et al. 2010. Nat Rev Microbiol. 8: 281-9. PMID: 20190824
  3. Mupirocin: biosynthesis, special features and applications of an antibiotic from a gram-negative bacterium.  |  Gurney, R. and Thomas, CM. 2011. Appl Microbiol Biotechnol. 90: 11-21. PMID: 21336932
  4. Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.  |  Serafini, F., et al. 2011. Appl Environ Microbiol. 77: 3141-6. PMID: 21421794
  5. Mupirocin reduces ciliary beat frequency of human nasal epithelial cells.  |  Birk, R., et al. 2016. Eur Arch Otorhinolaryngol. 273: 4335-4341. PMID: 27342406
  6. Electrospun PCL/mupirocin and chitosan/lidocaine hydrochloride multifunctional double layer nanofibrous scaffolds for wound dressing applications.  |  Li, X., et al. 2018. Int J Nanomedicine. 13: 5287-5299. PMID: 30237715
  7. High-level mupirocin resistance in methicillin-resistant staphylococci isolated from dogs and cats.  |  Kizerwetter-Świda, M., et al. 2019. BMC Vet Res. 15: 238. PMID: 31291949
  8. Safety and Biocompatibility of Mupirocin Nanoparticle-Loaded Hydrogel on Burn Wound in Rat Model.  |  Kamlungmak, S., et al. 2021. Biol Pharm Bull. 44: 1707-1716. PMID: 34719647
  9. Dynamics of the Catalytic Active Site of Isoleucyl tRNA Synthetase from Staphylococcus aureus bound with Adenylate and Mupirocin.  |  Chowdhury, S. and Nandi, N. 2022. J Phys Chem B. 126: 620-633. PMID: 35015537
  10. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid.  |  Hughes, J. and Mellows, G. 1978. Biochem J. 176: 305-18. PMID: 365175
  11. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.  |  Sutherland, R., et al. 1985. Antimicrob Agents Chemother. 27: 495-8. PMID: 3923922
  12. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens.  |  Fuller, AT., et al. 1971. Nature. 234: 416-7. PMID: 5003547
  13. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA).  |  Eltringham, I. 1997. J Hosp Infect. 35: 1-8. PMID: 9032630

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Pseudomonic Acid, 25 mg

sc-202299
25 mg
$173.00